SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bharat Rasayan Ltd (BHARATRAS)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 590021 NSE: BHARATRAS Pesticides & Agrochemicals | Small Cap | Bharat Rasayan Share Price

₹1,338.85 -8.60 (-0.64%)

As on 02-Jul'26 16:59

Bharat Rasayan Ltd (BHARATRAS)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 590021 NSE: BHARATRAS Pesticides & Agrochemicals | Small Cap | Bharat Rasayan Share Price

₹1,338.85 -8.60 (-0.64%)

As on 02-Jul'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹2,225 Cr.
Current Price
₹1,338.9
52-Week Low / High
₹1,202 / 3,030
TTM EPS
₹87.7
TTM Sales
₹1,242 Cr.
Book Value per Share
₹766.9
P/E Ratio
15.27
Lower than its 5-year historical median
Industry PE
30.4
Price to Book (P/B)
1.75
Lower than its 5-year historical median
Price to Sales (P/S)
1.79
Lower than its 5-year historical median
EV/EBITDA
9.17
Lower than its 5-year historical median
Dividend Yield
0.03%
Profitability Efficiency
Return on Equity (ROE)
13.31%
In line with industry median
Return on Capital Employed (ROCE)
16.63%
In line with industry median
Return on Assets (ROA)
10.81%
Operating Profit Margin
14.9%
Net Profit Margin
12.01%
Gross Profit Margin
16.7%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
12.29%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
48.76%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
47.54%
Asset Quality
Promoter Holding
74.99%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹1,266 Cr.
Equity
₹8.3 Cr.
Face Value
₹5
All Time Low / High
₹5.38 / 3775.00

Bharat Rasayan stock performance

Key Ratios
mw4me loader

Check Before You Invest

Valuation

Somewhat Undervalued

Price Trend

Weak
Q.1 Is Bharat Rasayan Ltd a good quality company?
Bharat Rasayan Ltd is a good quality company, based on a consistently good multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Bharat Rasayan Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Bharat Rasayan Ltd vs industry peers?
Bharat Rasayan Ltd revenue CAGR is -0.70%, compared to the industry median CAGR of 8.45%, indicating slower growth and losing its market share.
Q.1 Promoter shareholding and pledge status of Bharat Rasayan Ltd?
Promoters hold 74.99% of the Bharat Rasayan Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Bharat Rasayan Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 17.4% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Bharat Rasayan Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 0%0%0%26.1%33.7%30.5%27.9%19.3%12.7%16.6%-
Value Creation
Index
NANANA0.91.41.21.10.4-0.10.2-

Growth Parameters

Sales 0009921,2151,0921,3011,2341,0451,1731,242
Sales YoY Gr.-NANANA22.5%-10.1%19.1%-5.1%-15.4%12.3%-
Adj EPS 00065.78895.7100.569.451.881.287.7
YoY Gr.-NANANA34%8.7%5.1%-31%-25.4%56.9%-
BVPS (₹) 000240.6331.9428463.3537.5594.4679.9766.9
Adj Net
Profit
00011215016316711586135146
Cash Flow from Ops. 000-52.3263170-65.521341.1172-
Debt/CF from Ops. 000-4.70.40.3-2.70.120.5-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales NA-0.7%-3.4%12.3%
Adj EPS NA-1.6%-6.9%56.9%
BVPSNA15.4%13.6%14.4%
Share Price 16.3% -17.1% -17.6% -52.9%

Key Financial Parameters

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
00027.330.725.222.313.99.212.712.1
Op. Profit
Mgn %
00018.918.92219.31611.314.916
Net Profit
Mgn %
00011.312.314.912.89.48.211.511.7
Debt to
Equity
0000.60.20.10.200.10.10
Working Cap
Days
0000155165185228264246167
Cash Conv.
Cycle
0000119125148181198175138

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales9921,2151,0921,3011,2341,0451,173
Operating Expenses + 8059858521,0491,037927998
Manufacturing Costs40495672716479
Material Costs684839684843839721777
Employee Cost 40465665677384
Other Costs 41505570606958
Operating Profit 187230240252197118175
Operating Profit Margin (%) 18.9%18.9%22.0%19.3%16.0%11.3%14.9%
Other Income + 317716192126
Exceptional Items -2-3-1-0-400
Interest 161647635
Depreciation 17222625262627
Profit Before Tax 155205215234174123185
Tax 44485158492844
Profit After Tax 11215816417612596141
PAT Margin (%) 11.2%13.0%15.0%13.5%10.1%9.1%12.0%
Adjusted EPS (₹)65.692.896.4105.975.057.584.8
Dividend Payout Ratio (%)0.60%0.40%0.40%0.40%0.50%0.70%0.40%

Valuation of Bharat Rasayan - Consolidated

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 4095647277708939881,130
Share Capital 4444444
Reserves 4055607237668899841,126
Debt +2479458174288085
Long Term Debt402201000
Short Term Debt2077258173288085
Minority Interest0000000
Trade Payables453961687573142
Others Liabilities 55556178805752
Total Liabilities 7567529081,0901,0761,1981,409

Fixed Assets

Net Fixed Assets +150203191228225230230
Gross Block276352365427449480504
Accumulated Depreciation126148174199224250274
CWIP 3518181111615
Investments 091504367143298
Inventories210160169277323267290
Trade Receivables279251296464325394419
Cash Equivalents 951336344956
Others Assets 7160526092109100
Total Assets 7567529081,0901,0761,1981,409

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + -52263170-6521341172
PBT 155205215234174123185
Adjustment 312124201917
Changes in Working Capital -19589-18-26170-5418
Tax Paid -44-52-51-58-51-29-38
Cash Flow From Investing Activity + -48-68-15351-61-90-157
Capex -48-58-11-55-22-27-35
Net Investments 0-9-142106-30-62-138
Others 0-1-01-9-116
Cash Flow From Financing Activity + 102-169-40-25-15249-1
Net Proceeds from Shares 0000000
Net Proceeds from Borrowing 0000-100
Interest Paid -15-15-4-7-6-3-5
Dividend Paid -1-1-1-1-1-1-1
Others 119-153-35-17-145535
Net Cash Flow 325-22-391014

Financial Ratio

PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)27.2832.4125.3823.5114.9810.1513.31
ROCE (%)26.1433.7430.4527.8719.3112.7416.63
Asset Turnover Ratio1.311.611.321.31.140.920.9
PAT to CFO Conversion(x)-0.461.661.04-0.371.70.431.22
Working Capital Days
Receivable Days102.7079.6091.30106.50116.60125.60126.50
Inventory Days77.3055.705562.5088.8010386.70
Payable Days23.8018.2026.802831.1037.4050.50

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.640.640.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Bharat Rasayan Ltd FAQs

The current trading price of Bharat Rasayan on 02-Jul-2026 16:59 is ₹1,338.9.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jul-2026 the market cap of Bharat Rasayan stood at ₹2,225.3 Cr

The latest P/E ratio of Bharat Rasayan as of 01-Jul-2026 is 15.57.

The latest P/B ratio of Bharat Rasayan as of 01-Jul-2026 is 1.78.

The 52-week high of Bharat Rasayan is ₹3,030.3 and the 52-week low is ₹1,202.1.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Bharat Rasayan is ₹1,242 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Bharat Rasayan Ltd is a good quality company.

The key valuation ratios of Bharat Rasayan Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Bharat Rasayan Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Bharat Rasayan Ltd

Bharat Rasayan (BRL), flagship company of Bharat Group, was set up on May 15, 1989 as a backward integration project to manufacture Technical Grade Pesticides and Intermediates In-compliance to International Standards. Within two years from incorporation, BRL commenced production at its fully equipped plant located in Mokhra village of Rohtak district in Haryana. Another modern and larger plant in the Chemical Approved Zone at Dahej in Gujarat was set up to manufacture tech grade pesticides, intermediates and bulk formulations. Both the units have in-house R&D laboratories to ensure consistent perfection in quality and also to act as pilot plants for new products and formulations.

The Initial Public Issue by BRL in 1993 evinced an overwhelming response. Currently listed on NSE, the company became a major stakeholder in the Tata owned Siris Crop Sciences Ltd. and even acquired it in due course.

Bharat Group is the brainchild of the visionary and industry veteran S.N. Gupta, supported with two like-minded partners M.P. Gupta and R.P. Gupta. Banking over years of rich experience, Bharat group is strongly present in all business verticals i.e. Technical/Intermediate Corporate Sales, Contract Manufacturing for various MNC's, Domestic Brand Sales, International Business and P2P (Peer-to-Peer) Toll Formulation Business. Bharat Group’s agri-input solutions range from Insecticides, Fungicides, Herbicides and Intermediates. 

Business area of the company

The company is engaged in the manufacturing and sale of technical grade pesticides and chemical intermediates.

Milestones 

  • 1989: As a part of backward integration, Bharat Group established Bharat Rasayan Limited, Mokhra with focus on A.I. Manufacturing.
  • 1993: Bharat Rasayan Limited stock was listed at National Stock Exchange and BSE.
  • 2003: Acquired Siris Crop Science Ltd. from Tata House to further strengthen A.I. manufacturing.
  • 2005: Established additional modern formulation units of Bharat Insecticides Limited to boost Domestic Brand Sales & Toll manufacturing.
  • 2010: Bharat Rasayan Limited starts contract manufacturing for Japanese Partner 
  • 2010: Siris Crop Science Ltd. was merged in Bharat Rasayan Limited.
  • 2012: Bharat Rasayan Limited started additional state-of-art manufacturing facility at Dahej, Gujarat. 
  • 2012: The company started contract Manufacturing for big European MNC and another Japanese Partner.
  • 2019: The company raised funds through issue of Commercial Paper (CP) worth Rs 220 crore on January 03, 2019
  • 2020: The company further expands the capacity of MPBD.
  • 2020: The company starts manufacturing of CMAC as part of backward integration. 
  • 2020: The company starts manufacturing of Permethrin Technical, Cypermethrin Technical, Alpha-Cypermethrin, Technical and Zeta-Cypermethrin Technical.
  • 2020: The company gets registration of Bifenthrin Technical in Brazil and Metribuzin Technical in USA.
  • 2020: The company enters into a Joint Venture with Nissan Chemical Corporation Japan to setup a Technical Plant under new company name: Nissan Bharat Rasayan Private Limited.
  • 2022: The company acquired land at Dahej-3, Industrial Estate from Gujarat Industrial Development Corporation Authority (GIDC) for future expansion and new projects.

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: